Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV‑2/Covid 19-Pandemie
Standard
Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV‑2/Covid 19-Pandemie. / Schulze-Koops, H; Holle, J; Moosig, F; Specker, C; Aries, P; Burmester, G; Fiehn, C; Hoyer, B; Krause, A; Leipe, J; Lorenz, H-M; Schneider, M; Sewerin, P; Voormann, A; Wager, U; Krüger, K; Iking-Konert, C; im Auftrag der Kommission Pharmakotherapie und des Vorstandes der Deutschen Gesellschaft für Rheumatologie.
in: Z RHEUMATOL, Jahrgang 79, Nr. 4, 05.2020, S. 385-388.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV‑2/Covid 19-Pandemie
AU - Schulze-Koops, H
AU - Holle, J
AU - Moosig, F
AU - Specker, C
AU - Aries, P
AU - Burmester, G
AU - Fiehn, C
AU - Hoyer, B
AU - Krause, A
AU - Leipe, J
AU - Lorenz, H-M
AU - Schneider, M
AU - Sewerin, P
AU - Voormann, A
AU - Wager, U
AU - Krüger, K
AU - Iking-Konert, C
AU - im Auftrag der Kommission Pharmakotherapie und des Vorstandes der Deutschen Gesellschaft für Rheumatologie
PY - 2020/5
Y1 - 2020/5
N2 - In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these questions cannot yet be answered on an evidence-based basis and this does not make patient care easy. The German Society for Rheumatology (DGRh) hopes that these initial recommendations will provide support for specific issues in the care of patients with inflammatory rheumatic diseases in view of the current threat posed by SARS-CoV-2. In order to take advantage of the dynamic worldwide gain in knowledge for our patients, the recommendations will be updated regularly. The updated versions of the recommendations are deposited on the homepage of the DGRh.
AB - In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these questions cannot yet be answered on an evidence-based basis and this does not make patient care easy. The German Society for Rheumatology (DGRh) hopes that these initial recommendations will provide support for specific issues in the care of patients with inflammatory rheumatic diseases in view of the current threat posed by SARS-CoV-2. In order to take advantage of the dynamic worldwide gain in knowledge for our patients, the recommendations will be updated regularly. The updated versions of the recommendations are deposited on the homepage of the DGRh.
KW - Betacoronavirus
KW - COVID-19
KW - Coronavirus Infections/complications
KW - Guidelines as Topic
KW - Humans
KW - Immunosuppressive Agents/therapeutic use
KW - Pandemics
KW - Pneumonia, Viral/complications
KW - Rheumatic Diseases/complications
KW - Rheumatology/standards
KW - SARS-CoV-2
KW - Societies, Medical
U2 - 10.1007/s00393-020-00799-y
DO - 10.1007/s00393-020-00799-y
M3 - SCORING: Review
C2 - 32342184
VL - 79
SP - 385
EP - 388
JO - Z RHEUMATOL
JF - Z RHEUMATOL
SN - 0340-1855
IS - 4
ER -